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1. SUMMARY 
 
Title: Right ventricular loading conditions in left ventricular assist device recipients 
 
Author: Ana Gaberšek 
 
Summary:  
A ventricular assist device is a type of mechanical circulatory support used in patients 
with advanced heart failure. Left ventricular assist devices (LVAD) can be used as 
destination therapy, where they are an alternative to heart transplantation, bridge to 
transplant therapy or bridge to recovery therapy. The most common complication in the 
immediate postoperative period after LVAD implantation is right ventricular failure. It is 
challenging to determine which patients may develop right ventricular failure in the 
postoperative period, and there is no equivocal evidence in the literature suggesting 
which parameters might be optimal in predicting right ventricular failure (RVF).  
The aim of this study was to identify and obtain clinical, hemodynamic and 
echocardiographic parameters that could successfully predict RVF in LVAD recipients. 
For this we have studied 40 consecutive patients at the University Hospital Centre Zagreb 
in which we have measured parameters of heart geometry and function by 
echocardiography, as well as functional and hemodynamic values by right heart 
catheterization which were used in combination with clinical parameters for the 
prediction of early and late RVF.  
 
 
 
Key words: advanced heart failure, ventricular assist device, right heart failure, right 
ventricular function.  
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2. PREFACE 
 
2.1. HEART FAILURE 
Heart failure is a condition which occurs when heart function is too poor to pump a 
sufficient amount of blood to meet the needs of a body. Some causes of heart failure 
are: previous coronary artery disease with myocardial infarction, arterial hypertension, 
various cardiomyopathies, arrhythmias, congenital heart defects and dysfunction of 
heart valves. Signs and symptoms of heart failure include shortness of breath (dyspnea), 
lung edema, edema of extremities, intolerance of physical activity, fatigue, syncope, 
hepatosplenomegaly, inability to lie flat (orthopnea) and waking up during the night due 
to shortness of breath (paroxysmal nocturnal dyspnea).  
 
2.2. HEART FAILURE CLASSIFICATION 
According to the American Heart Association [1], there are four functional classes, to 
which we can assign patients according to their symptoms of heart failure. Patients 
without limitation of physical activity or patients whose ordinary physical activity does 
not cause undue fatigue, palpitation, dyspnea would be assigned to New York Heart 
Association (NYHA) Class I. Patients with slight limitation of physical activity, that are 
comfortable at rest or patients, in which ordinary physical activity results in fatigue, 
palpitations, dyspnea would be assigned to NYHA Class II. Patients with a marked 
limitation of physical activity, that are comfortable at rest, or patients in which less than 
ordinary activity causes fatigue, palpitation, or dyspnea would be assigned to NYHA 
Class III. Patients who are unable to carry on any physical activity without discomfort, 
patients that have symptoms of heart failure at rest and patients in which, if any physical 
activity is undertaken, discomfort increases are classified as NYHA Class IV.  
 
In early stages of heart failure, symptoms can be managed with optimal medical therapy 
and lifestyle modification, however, this may become insufficient due to heart 
weakening as the condition progresses. According to the European Society of 
Cardiology 2016 Guidelines, one can describe heart failure as advanced heart failure 
when patients experience repeated cardiac decompensations, severe symptoms of heart 
failure or severe dysfunction of the heart [2].  
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2.3. TREATMENT OPTIONS FOR PATIENTS WITH HEART FAILURE  
There are two main treatment options for advanced heart failure patients. One of the 
options is orthotopic heart transplantation – a surgical procedure by which a patient’s 
own failing heart is replaced through median sternotomy with a donor heart [3]. The 
alternative option is treatment with mechanical circulatory support (MCS) which 
encompasses surgical or percutaneous implantation of various devices – amongst others, 
ventricular assist devices. Left ventricular assist devices are mechanical pumps, that are 
implanted in order to aid the failing left ventricle in providing adequate circulation to 
the body [4].  
Ventricular assist devices can be classified according to the nature of blood flow they 
produce into pulsatile devices, driving blood in pulsatile manner and continuous flow 
devices, producing axial blood flow [4,5]. 
 
2.4. PATIENT SELECTION FOR LVAD IMPLANTATION 
Patient selection for left ventricular assist device (LVAD) implantation is cumbersome. 
There are numerous factors that need to be carefully studied when selecting patients. 
Detailed evaluation of echocardiographic parameters and values obtained by right 
ventricular catheterization has to be performed. Comorbidities such as age, chronic 
kidney disease and diabetes also need to be taken into consideration, since they can 
have a great impact on outcomes in LVAD recipients. There are multiple other factors 
also influencing patient outcomes after LVAD implantation, and it is not yet clear 
which are most relevant.  
 
2.5. COMPLICATIONS FOLLOWING LVAD IMPLANTATION 
Patients who received LVAD are at risk for developing driveline infection, 
thromboembolic events, postoperative bleeding and right ventricular failure (RVF) [5]. 
Infection of a transcutaneous driveline is common and it is associated with increased 
morbidity and mortality. A driveline infection can occur at the time of insertion or at 
any time in the postoperative period. Most driveline infections occur after the first 30 
days after surgery [6].  
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Risk of developing thromboembolic events after LVAD implantation accounts for less 
than 20% of complications [3], regardless of the type of the device. Incidence of  
postoperative bleeding is still higher than 20%, and it remains one of the most common 
complications following LVAD placement, mostly requiring redo surgical procedures 
[7]. 
 
2.6. THE RIGHT VENTRICLE 
The right ventricle is one of the four chambers of the heart and it extends from the right 
atrium to the apex of the heart, forming the majority of the anterior heart surface. It has 
an inlet section (sinus section) and an outlet (conus) section which are separated by the 
crista supraventricularis. The right ventricular wall has two layers of muscles. 
Superficial muscle layer fibers extend to the left ventricle, which allows coordinated 
contractions of both ventricles [8, 9].   
 
Primary function of the right ventricle is the receival of systemic venous return and 
pumping it into the pulmonary arteries. Blood enters the right ventricle from the right 
atrium, through the tricuspid valve, and flows from the right ventricle through the 
pulmonary valve into the pulmonary trunk, which carries blood further to the lungs for 
oxygenation. Right ventricular function depends on the preload, afterload and 
contractility of the ventricle. Stroke volume of the right ventricle is the same as the 
stroke volume of the left ventricle, except that the right ventricle pumps with 
approximately 15% of the stroke work, due to low resistance and pressures in 
pulmonary circulation [8]. The dimensions and systolic function of the right ventricle 
can primarily be assessed with echocardiography, using a combination of various 
echocardiographic parameters.  
 
2.7. POSTOPERATIVE RV FAILURE 
The most common complication in the immediate postoperative period after LVAD 
implantation is right ventricular failure [10,11]; therefore, it is important to properly 
evaluate all the parameters that might facilitate the preoperative and postoperative risk 
assessment. According to the Interagency Registry for Mechanically Assisted 
Circulatory Support (INTERMACS) [12], right ventricular failure is defined as 
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persistent signs and symptoms of RV dysfunction evident by central venous pressure 
(CVP) > 18 mmHg with  cardiac index (CI) < 2.0 L /min/ m
2 
in the absence of increased 
left atrial filling pressure/ pulmonary capillary wedge pressure (PCWP) >18 mmHg, 
cardiac tamponade, ventricular arrhythmias and/or pneumothorax, requiring either 
RVAD implantation, inhaled nitric oxide or inotropic therapy for 14 days or more after 
LVAD has been implanted. 
 
INTERMACS [12] further classifies RVF according to severity in three classes: 
- Severe, when RVAD is required 
- Moderate, when there is a need for inotropes or inhaled pulmonary vasodilators 
- Mild, when two or more of the following signs and symptoms are present: CVP 
>18 mmHg, CI < 2.3 L/min/m
2
, ascites, moderate to severe peripheral edema, 
evidence of high CVP on physical examination or transthoracic echocardiogram, 
but without the need for RVAD or inotropic/vasodilator support. 
 
Right ventricular failure after LVAD implantation occurs because of the alteration of  
Frank – Starling forces of the right ventricle as a result of unloading of the left ventricle, 
which leads to an increase of cardiac output and increase in preload of an already 
weakened and poorly contracting right ventricle, that has to pump against high 
afterload. Additionally, the worsening of tricuspid regurgitation (TR) and leftward 
bowing of the septum can occur, which further aggravates this condition [12]. 
 
2.8. ECHOCARDIOGRAPHY 
Echocardiography is a non-invasive technique of visualisation of the heart, which can 
be used for diagniostic and therapeutic purposes. With echocardiography it is possible 
to obtain information about heart chamber geometry and myocardial structure and 
function, including the assesment of cardiac hemodynamic properties (by Doppler 
echocardiography). Echocardiography can also assess the morphology and function of 
the heart valves, aid in the detection of masses within the heart and assessment of the 
pericardium.  
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2.8.1. ECHOCARDIOGRAPHIC IMAGES 
Ultrasound transducers use piezoelectric crystals, which have the ability to transform 
electrical oscilations into mechanical oscilations, to generate and receive ultrasound 
waves. The formation of the image is based on the time interval between the 
transmission of the ultrasound and return of the reflected signal back to the transducer 
(probe), which means that the image formation is related to the distance of a structure 
from the transducer. Several imaging modalities exist in echocardiography: two-
dimensional (2-D) imaging, motion or so called ''M''-mode imaging, Doppler imaging 
(continuous wave, pulsed wave and color flow), as well as advanced imaging 
techniques such as three-dimensional (3-D) imaging and deformation imaging (strain 
and strain-rate imaging).  
 
A two-dimensional image is generated through complex manipulation of the returned 
signal (time-gain compensation, signal amplification, filtering, compression and 
rectification), to form a final image displayed on the echocardiography monitor. The  
2-D mode captures a snapshot of the tissue cross-section and when those snapshots are 
produced quickly in a short amount of time, this allows the real-time imaging of the 
heart [8]. When the signal is produced and returned along one line, this denotes the 
motion mode. Motion mode (M-mode) has high sensitivity in detection of moving 
structures at high temporal resolution, which is of great importance in the identification 
of subtle heart abnormalities, such as for example valve leaflet abnormalities. Since it 
shows the motion of the heart, it also enables the operator to measure heart dimensions 
such as the size of heart chambers during the heart cycle or heart muscle thickening, 
also allowing for the precise timing of such events within the heart cycle.  
 
The basic principle of Doppler echocardiography uses the detection of changes in 
frequency of the returned signal, that has been reflected from the red blood cells. 
Doppler echocardiography is mostly used to assess velocity information and to detect 
heart abnormalities such as shunts and valvular problems (stenoses, regurgitations, 
insufficiencies). Additionally color Doppler feature allows the operator to examine the 
flow of blood within the heart. 
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2.8.2. ECHOCARDIOGRAPHY WINDOWS 
Different placements of the ultrasound transducer allow us to visualise different planes 
of the heart. Possible transducer placements include: suprasternal, right and left 
parasternal, subcostal and apical. The heart can be visualised in several standard 
imaging planes: the long-axis plane, the short-axis plane and the apical four-, five-, two- 
and three-chamber planes.  
 
When placing the transducer at the left parasternal window, the operator is able to 
examine the long-axis view and short-axis views. The long-axis plane is the plane that 
slices the heart from its base to the apex of the heart. Many short-axis views can be 
obtained by changing of the angulation of the transducer, but usually the operator 
examines short-axis view at the level of the aortic valve, mitral valve, left ventricular 
papillary muscles and at the apex of the left ventricle [8]. The four-chamber view can be 
obtained through the apical window, with placement of the transducer to the apex of the 
heart.  
 
Another view obtained through the apical window is the five-chamber view, which is of 
great importance in determining aortic valve abnormalities, because it allows 
visualisation of the aortic valve and ascending aorta. The two-chamber view can be 
obtained by rotating the probe on the apex of the heart, which enables examination of 
the left ventricle. The subcostal window is used particularly when examining the 
interatrial septum, abdominal aorta and inferior vena cava.  
Additional windows include the suprasternal window, which can be used for 
examination of the aorta, and the right parasternal window, which is useful for 
ascending aorta examination. 
 
 
3. BACKGROUND 
Right ventricular failure is a very common early complication after LVAD implantation, 
however it is not yet possible to conclude, which variables are the most influential in 
risk estimation and complication prediction. 
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The aim of this study was to identify and obtain clinical, hemodynamic and 
echocardiographic parameters and derived models that could successfully predict RVF 
in LVAD recipients.  
 
 
4. METHODS 
Preoperative assessment of echocardiographic and RHC parameters was done for 40 
consecutive patients at the University Hospital Centre Zagreb (36 male and 4 female, 
mean age 60.4 ± 6.9 years), who have undergone continuous flow LVAD implantation 
(80% of patients received HeartMate II/III and 20% of patients HeartWare).  
Demographic data were obtained for all the patients and those included: age, gender, 
etiology of the disease (which was further divided into four subcategories: dilated 
cardiomyopathy (CMP), ischemic CMP, left ventricular noncompaction (LVNC), acute 
myocardial infarction (MI), previous cardiac surgery with or without concomitant aortic 
valve repair (AVR) and body surface area (BSA) (Table 1).  
 
Echocardiographic parameters were obtained through a complete standard transthoracic 
echocardiographic examination [13], which still remains the golden standard for 
assessment of left and right ventricular systolic and diastolic function as well as 
evaluation of pressures in pulmonary artery [2]. Upon echocardiographic examination 
of the right heart, it is important to evaluate both – function and structure of the right 
ventricle as well as right atrium. The best indicator of right ventricular systolic function 
is tricuspid annular plane systolic excursion (TAPSE), TAPSE lower than 17 mm 
indicates systolic dysfunction of the right ventricle [13]. Right ventricular fractional 
area change (RVFAC) represents another important parameter for evaluation of right 
ventricular systolic function and is calculated as a difference of right ventricular end 
diastolic area and right ventricular end systolic area, being further divided by right 
ventricular end diastolic area times one hundred [14]. For the purpose of our studies of 
RV geometry, we have defined the right ventricular asymmetry (RVA) index as a ratio 
of the difference of the medial and lateral portion of RV area in relation to total RV area 
at end diastole (Figure 1.).  
    
 
 8 
Parameters obtained with echocardiographic examination of the right heart for this 
study were: right ventricular internal dimension in diastole (RVIDd), right ventricle 
(RV) length, right atrium volume indexed to BSA (RAVol/BSA), TAPSE, RVFAC and 
RVA index.  
 
Other parameters were obtained through Swan-Ganz heart catheterization. During the 
Swan – Ganz catheterization, a thin catheter is positioned in the subclavian, femoral or 
jugular vein through a vascular sheath introduced by means of the Seldinger technique. 
The catheter is further advanced to the right heart, followed by the pulmonary artery, up 
to the wedge position. In this study, the Swan-Ganz method was used to obtain the 
following parameters: CI, systolic pulmonary artery pressure (sPAP), diastolic 
pulmonary artery pressure (dPAP), mean pulmonary artery pressure (mPAP), 
pulmonary capillary wedge pressure (PCWP), peripheral vascular resistance (PVR), 
transpulmonary gradient (TPG), right atrial pressure (RAP) and right ventricular stroke 
work index (RVSWI).  
 
Figure 1. Right ventricular asymmetry (RVA) index defined as a ratio of the difference 
of the medial (B) and lateral (A) portion of the RV area in relation to total RV area at 
end diastole.  
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The patients were divided into two groups, according to the development of 
postoperative RV failure (defined by the INTERMACS criteria). The RV failure group 
consisted of 6 patients, while the remaining 34 patients were within the non-RV failure 
group.  
 
The statistic analysis was performed using Microsoft Office Excel and SPSS programs. 
For group comparison Pearson chi square and Student's t–test were used. The p value 
<0.05 was deemed statistically significant. Fisher's exact test was used for the tables of 
contingency, while the ROC curves were used for the calculation of the AUC.  
 
 
 
5. RESULTS 
The demographic characteristics of both groups are presented in Table 1. Six out of 
forty patients (15%) developed RV failure after LVAD implantation. Mean age of 
patients in RV failure group was 58.7±6.0 years. In this group, there were 5 male 
patients and 1 female patient. Cardiac disease etiology varied within the group: one 
patient had dilated CMP and five patients had ischemic CMP. Two out of six patients 
had a history of previous cardiac surgery, but none of them had the concomitant AVR 
procedure done during LVAD implantation. Average BSA within the group was 2.1±2.7 
m
2
. 
 
Thirty-four out of forty patients (85%) did not develop RV failure after LVAD 
implantation. Mean age of the Non-RV failure group was 61.5±5.5 years. In this group 
there were 31 male patients and 3 female patients. The leading cause of cardiac disease 
was ischemic CMP (68%), followed by dilated CMP (27%) and LVNC (5%). Five 
patients had a history of previous cardiac surgery, and five patients had the concomitant 
AVR procedure performed. Average BSA for non-RV failure group was 2.0±0.2 m2. 
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Table 1. Demographic characteristics of studied population 
Characteristic 
 
Number of pts 
RV failure 
 
6/40 (15%) 
Non-RV failure 
 
34/40 (85%) 
p value 
 
Age 
 
 
     58.7±6.0 
 
         61.5±5.5  
 
0.485 
Gender 
- male 
- female 
 
5/6 (83%) 
1/6 (17%) 
 
31/34 (91%) 
3/34 (9%) 
 
 
Disease etiology: 
- dilated CMP 
- ischemic CMP 
- LVNC 
- acute MI 
 
 
1/6 (17%) 
5/6 (83%) 
0/6 
0/6 
 
 
 
  9/34 (27%) 
23/34 (68%) 
          2/34 (6%) 
0/34 
 
 
Previous cardiac surgery 
 
Concomitant AVR 
 
 
2/6 (33%) 
 
0/6 
 
5/34 (15%) 
 
5/34 (15%) 
 
 
BSA (m
2
) 
 
 
2.1±2.7 
 
 
2.0±0.2 
 
 
0.493 
 
 
 
Table 2 compares echocardiographic data for both groups of patients. 
Echochardiographic evaluation of patients in  the RV failure group showed that average 
RVIDd was enlarged at 43.8±5.7 mm, average RV length was 85±9.0 mm and 
RAVol/BSA ratio was calculated to be 53.6±18.3 ml/m2, also indicating RA dilatation. 
Right ventricular systolic function was also on average mildly reduced: TAPSE was 
12.3±3.1 mm, and the average value of right ventricular fractional area was 24.3±11.7. 
The RVA index was calculated to be 0.2±0.1. 
 
In the non-RV failure group, the measurements of RA and RV geometry also 
demonstrated an enlargement of these cavities: the average RVIDd was 40.8±7.0 mm. 
This group had an average RV length of 88.4±11.8 mm. RAVol/BSA ratio was 
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calculated and it was 39.7±13.8 ml/m2. TAPSE was 14.6±4.3 mm. RVFAC was also 
reduced at 25.9±7.4 %. Average value of RVA index for this group was 0.4±0.1. 
 
The only parameter that showed statistically significant difference (p=0.0001) between 
the two groups was the RVA index, being significantly higher (indicating greater RV 
asymmetry) in the group of patients without RV failure, than in the RV failure group. 
 
 
Table 2. Echocardiography data pertaining to right ventricular morphology and function 
Parameter 
 
Number of pts 
RV failure 
 
6/40 (15%) 
Non-RV failure 
 
34/40 (85%) 
p value 
 
 
RVIDd (mm) 
 
 
43.8±5.7 
 
40.8±7.0 
 
0.286 
 
 
RV length (mm) 
 
 
85±9.0 
 
88.4±11.8 
 
0.440 
 
RAVol/BSA (ml/m
2
) 
 
 
53.6±18.3 
 
39.7±13.8  
 
0.127 
 
TAPSE (mm) 
 
 
12.3±3.1 
 
14.6±4.3 
 
0.163 
 
RVFAC (%) 
 
 
24.3±11.7 
 
25.9±7.4  
 
 
0.762 
 
RVA index 
 
 
0.2±0.1 
 
0.4±0.1 
 
0.0001 
 
 
 
Table 3 summarizes the data obtained during right heart catheterization. CI was similar 
in the RV failure and in the non-RV failure group (1.6±0.4 vs. 1.8±0.4 L/min/m2 
respectively). There were no statistically significant differences in sPAP, mPAP, 
PCWP, PVR, TPG, RVSWI between the two groups.  
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The only variable that was statistically significantly different between the two groups 
was right atrial pressure. In the RV failure group RAP was 16.7±4.1 mmHg and in the 
non-RV failure group it was 9.7±5.2 mmHg (p=0.006). 
 
 
Table 3. Right heart catheterisation data 
Parameter     RV failure Non-RV failure p value 
 
 
CI (L/min/m
2
) 
 
 
1.6±0.4 
 
1.8±0.4 
 
0.295 
 
sPAP (mmHg) 
 
 
74±19.1 
 
63.1±18.7 
 
0.231 
 
mPAP (mmHg) 
 
 
47.3±6.7 
 
41.6±12.4 
 
0.145 
 
PCWP (mmHg) 
 
 
27.2±5.2 
 
26.5±8.5 
 
0.862 
 
PVR (dynes/cm
2
) 
 
 
6.5±3.0 
 
4.5±2.2 
 
0.188 
 
TPG (mmHg) 
 
 
20.2±9.0 
 
 
15.1±6.4 
 
0.241 
 
RAP (mmHg) 
 
 
16.7±4.1 
 
9.7±5.2 
 
0.006 
 
RVSWI (g/m
2
/beat) 
 
 
10.8±6.6 
 
9.4±2.4 
 
0.667 
 
 
 
 
Table 4 shows how various Swan-Ganz and echocardiographic variables alone or in 
combination perform in the prediction of post-LVAD RVF. The combination of  
RAVol/BSA, RVA and PVR, as well as the combination RAVol/BSA, RVA and TPG 
showed the optimal combination of high specificity (100%) and sensitivity (67%), with 
the highest Receiver-operating characteristics area under curve (ROC AUC) of 0.833.  
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Conversely, the markers routinely used to assess RV function, such as FAC and 
TAPSE, failed to predict the development of RV failure after LVAD implantation.  
 
 
Table 4. Swan-Ganz and echocardiographic variables in the prediction of post-LVAD 
RV failure  
Parameter ROC AUC Sensitivity Specificity p value (chi square) 
 
RAVol/BSA + RVA 
 
0.778 
 
67% 
 
89% 
 
0.006 
 
RAVol/BSA + RVA + CI 
 
0.713 
 
50% 
 
93% 
 
0.022 
 
RAVol/BSA + RVA + sPAP 
 
0.815 
 
67% 
 
96% 
 
0.001 
 
RAVol/BSA + RVA + CVP 
 
0.713 
 
50% 
 
93% 
 
0.026 
 
RAVol/BSA + RVA + PVR 
 
0.833 
 
67% 
 
100% 
 
<0.0001 
 
RAVol/BSA + RVA + TPG 
 
0.833 
 
67% 
 
100% 
 
<0.0001 
 
FAC 
 
0.38 
 
50% 
 
26% 
 
0.357 
 
TAPSE 
 
0.694 
 
83% 
 
56% 
 
0.182 
 
TAPSE + FAC 
 
0.441 
 
33% 
 
55% 
 
0.680 
 
 
 
 
 
 
 
    
 
 14 
6. DISCUSSION  
Patients with advanced heart failure have two main treatment options. The first option is 
heart transplantation and the second is the implantation of an LVAD. Right ventricular 
failure is one of the most common complications in the immediate postoperative period 
following LVAD implantation, therefore preoperative evaluation of patients and 
postoperative risk assessment are of crucial importance. However, numerous factors and 
comorbidities influence the final outcome in each individual, which encumbers the 
prediction of right ventricular failure. Unfortunately, it is not yet clear which of the 
clinical, echocardiographic or hemodynamic variables significantly impacts outcome 
prediction.  
 
Many studies have been performed in order to predict RVF failure after LVAD 
implantation. Study by Argiriou et al. [15] suggested that risk for developing RVF is 
low in the setting of the following combination of hemodynamic parameters: CVP ≤8 
mmHg, PCWP≤18 mmHg, CVP/PCWP ≤0.66, PVR<2 dynes/cm2 and RVSWI ≥ 400 
mmHg mL/m
2
. Raina et al. [16] compared echocardiographic parameters between 
patients who developed RVF and patients who did not develop RVF after implantation 
of LVAD. The authors concluded that preoperative evaluation of RVFAC (which was 
significantly lower in in patients who developed RVF compared to patients without 
RVF), RAP (which was significantly higher in RVF group of patients), LAV index (that 
was lower in RVF group of patients) could predict the likelihood of postoperative RVF. 
Puwanant et al. [17] compared echocardiographic parameters of the right ventricle 
between two groups of patients – group who developed RVF and group without RVF. 
Parameters obtained with echocardiographic examination included tricuspid annular 
motion, RVFAC, RAVol index, hepatic vein Doppler velocities, RV systolic pressures, 
RV index of myocardial performance and tricuspid regurgitation severity. The study 
displayed that patients who developed postoperative RVF had lower preoperative 
tricuspid annular motion and higher RV systolic pressures. Other parameters showed no 
significant difference between the two groups. The authors concluded that tricuspid 
annular motion can be considered a predictor of RVF after LVAD implantation.  
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Echocardiographic parameters of RV geometry and function and hemodynamic data 
obtained by right heart catheterization are complementary methods routinely used in the 
preoperative assessment of LVAD candidates. Thus, the aim of this study was to 
determine which parameter or which combination of parameters obtained by these two 
methods would show the greatest accuracy and reliability for predicting right ventricular 
failure in left ventricular assist device recipients. Based on our data, the routinely used 
echocardiographic and RHC parameters have failed to show statistically significant 
differences among patients with and without RV failure. The exception was the novel 
marker of RV geometry, the RVA index, which was significantly higher (indicating 
greater RV asymmetry) in the group of patients without RV failure than in the RV 
failure group (0.4±0.1 vs 0.2±0.1 respectively, p<0.0001), as well as the RAP, which 
was higher in the RV failure group (16.7±4.1 vs. 9.7±5.2 mmHg, respectively, 
p=0.006).  
 
Furthermore, the combination of right atrial volume indexed to BSA, right ventricular 
asymmetry and peripheral vascular resistance (RAVol/BSA + RVA + PVR, p<0.0001) 
as well as right atrial volume indexed to BSA, right ventricular asymmetry and 
transpulmonary gradient (RAVol/BSA + RVA + TPG, p<0.0001) were detected as 
superior predictors of post-LVAD right ventricular failure, performing better than e.g. 
the combination of TAPSE and FAC. 
 
We acknowledge that our study is limited by a small number of patients. However, it 
provides a basis for future research using a combination of echocardiographic 
parameters of right heart geometry and hemodynamic parameters of right ventricular 
loading conditions which may prove to be reliable predictors of right ventricular failure 
following LVAD implantation.  
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7. CONCLUSION 
Left ventricular assist device use increases with every day in medical practice. LVADs 
can be used as a destination therapy, where LVAD is used as an alternative to heart 
transplantation, as a bridge to transplant therapy, where mechanical circulatory support 
is used until the patient receives a donor heart, or as bridge to recovery therapy, where 
LVAD is used for chronically ill patients, that will after LVAD placement recover 
sustainable myocardial function. The selection of patients for the LVAD implantation is 
difficult, since many factors such as age and comorbidity influence the health outcome.  
Despite the limitations of this study, due to a small number of enrolled patients             
(40 patients), it was possible to demonstrate that echocardiographic parameters of RV 
and RA geometry (the RVA index and RA volume indexed to BSA) used in 
combination with RHC parameters of RV afterload (such as the PVR or TPG) may be 
accurate and reliable predictors of potential right ventricular failure after implantation of 
LVADs.  
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